Chemical and Biological Terrorism

Narcotics Buprenorphine, dextromoramide, diamorphine (heroin), methadone, morphine, pentazocine, pethidine and related substances 

Diuretics Acetazolamide, bumetanide, chlortalidone, etacrynic acid, furosemide, hydrochlorothiazide, mannitol, mersalyl, spironolone, triamterene and related substances 

Peptide hormones, Chorionic gonadotrophin, Pituitary and synthetic 

Agents with anti- Aromatase inhibitors, clomiphene, cyclofenil, 

Masking agents Diuretics, epitestosterone, probenecid, plasma expanders 

---

See, for example, Tracer Release Experiments at San Francisco International Airport to Improve Preparedness Against Chemical and Biological Terrorism, Sandia Report SAND2001-8380, Albuquerque, N.Mex. Sandia National Laboratories, June 2001. 

Shulga V., Delayed neuro-endocrine toxicity indused by organophosphorus compounds-natural consequence of poisonous substances application for terrorist purpose , In Medical Aspects of Chemical and Biological Terrorism -Chemical Terrorism and Tramautism, Alexander Monov and Christophor Dishovsky, eds, Publishing House of the Union of Scientists in Bulgaria, 2005 ( in press). 

Combating Terrorism Observations on the threat of Chemical and Biological Terrorism. Washington, D.C. U.. Government Accounting Office (T-NSIAD-00-50, Oct. 20) 1999. 

IOM/NRC, Chemical and Biological Terrorism Research and Development to Improve Civilian Medical Response, Institute of Medicine/National Research Council, National Academy Press, Washington, D.C., 1999. 

Source Adapted from Amy E. Smithson, Ataxia The Chemical and Biological Terrorism Threat and the US Response, Washington DC Henry L. Stimson Center (2003), p. 61. 

Institute of Medicine. (1999). Chemical and biological terrorism. Washington, DC National Academy Press. 

Similarly, there may be an increased incidence of psychogenic illness along with heightened concerns over chemical and biological terrorism. 

Smithson, A., Levy, L. (2000). Ataxia The chemical and biological terrorism threat and the U.S. response. Stimson Center Report, No. 35. Retrieved from http //www.stimson.org/... 

Institute of Medicine Nationai Research Council. (1999). Recognizing a covert exposure in a population. In Chemical and biological terrorism Research and development to improve civilian medical response (pp. 65-77). Washington, DC Nationai Academy Press. 

Veenema, T. (2003). Chemical and biological terrorism preparedness for staff development specialists. Journal for Nurses in Staff Development, 19(5), 215-222. 

My thanks go once again to Jonathan Tucker, my special contributor, for allowing me to reprint a portion of his work from his wonderful book Scourge The Once and Future Threat of Smallpox. It continues to be the perfect segue into the Chemical and Biological Terrorism section of the book. 

Purver, R., 2002. Chemical and biological terrorism the threat according to the open literature, Canadian Security and Intelligence Service, available at http //www.csis. scrs.gc.ca /eng/miscdocs/tabintr e.html. 

Salem, H. (2003). Issues in chemical and biological terrorism. International Journal of Toxicology 22 465-471. 

Simon, J.D., The emerging threat of chemical and biological terrorism, in General and Applied Toxicology, Volume 3, Second Edition, Ballantyne, B., Marrs, T.C., and Syversen, T., Eds., Macmillan, London, 1999, pp. 1722-1730. 

Smithson, A. and L.A. Levy. 2000. Ataxia the chemical and biological terrorism threat and the US response. In Stimson Center Report No. 35. Washington, DC Henry L. Stimson Center. 

---